-
Stock Watchlist For Next Week
Friday, July 22, 2011 - 6:29pm | 2279( click to enlarge ) BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) is forming a symmetrical triangle with support at $3.53. I am expecting a breakout at $3.79. So far, all indicators are in favor of an upward price movement: all the 3 major moving averages are below the current price and MACD...
-
No Respect: The Rodney Dangerfield of the Investment World
Friday, July 22, 2011 - 6:11pm | 1026Source: Photobucket Ask any average Joe off the street what investment category is at or near record all-time highs, and a good number of them will confidently answer “gold,” as prices recently eclipsed $1,600 per ounce. But of course this makes perfect sense, right? The Fed is printing money...
-
Watson Pharmaceuticals Confirms JALYN™ Patent Challenge
Friday, July 22, 2011 - 5:47pm | 86Watson Pharmaceuticals (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market dutasteride and tamsulosin hydrochloride capsules. Watson's dutasteride and...
-
NASDAQ Top Percentage Gainers: Marina Biotech, Mellanox, Datalink, Eagle Bulk Shipping
Friday, July 22, 2011 - 12:51pm | 507POINT ROBERTS - July 22, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 21, 2011. Marina Biotech, Inc. was the top gainer on the exchange with the stock closing higher by about 30% on Thursday....
-
Earnings Preview: Mylan Laboratories EPS, Revenue Expected to Rise from Previous Quarter
Friday, July 22, 2011 - 11:38am | 592Mylan Laboratories (NASDAQ: MYL) releases its next round of earnings this Wednesday, July 27, 2011. Get the latest predictions in Benzinga's essential guide to the company's second quarter earnings report. Earnings and Revenue: Analysts are predicting an EPS reading of 45 cents per share and...
-
Dr. Reddy's Acquires Prescription Business of JB Chemicals & Pharmaceuticals in Russia & Other CIS Markets for $34.85M
Friday, July 22, 2011 - 10:43am | 83Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has entered into an agreement with JB Chemicals & Pharmaceuticals to acquire their pharmaceutical prescription portfolio in the Russia and other CIS regions. The agreement involves acquisition of 20 brands, key ones being Metrogyl and...
-
Don't Miss Out On the Upcoming Boom in Biosimilars (RDY, SPPI)
Friday, July 22, 2011 - 10:11am | 879On Wednesday I wrote an article about biosimilars entitled, "Overlook this Sector and It Could Cost You." The article was about biosimilars and how for the first time in history (Patient Protection and Affordable Care Act) the generic alternative to name brand biologics would be available to...
-
Don't Miss Out On the Upcoming Boom in Biosimilars (RDY, SPPI)
Friday, July 22, 2011 - 10:11am | 879On Wednesday I wrote an article about biosimilars entitled, "Overlook this Sector and It Could Cost You." The article was about biosimilars and how for the first time in history (Patient Protection and Affordable Care Act) the generic alternative to name brand biologics would be available to...
-
Piper Jaffray Comments on Akorn Inc After Meeting With Top Management
Friday, July 22, 2011 - 9:31am | 175Piper Jaffray has published a report on Akorn Inc (NASDAQ: AKRX) after spending time with top management. In the report, Piper Jaffray wrote, "We just spent time with Akorn senior management. AKRX noted that annual growth for its base generics business (i.e., ophthalmics and injectables) is...
-
Deutsche Bank Maintains Eli Lilly Hold, $38.50 PT
Thursday, July 21, 2011 - 4:42pm | 98Deutsche Bank maintained its Eli Lilly (NYSE: LLY) Hold rating and $38.50 price target in a research report published today. In the report, Deutsche Bank states, " The upside risks to our Hold rating are that Effient sales exceed expectations, or the company does a large merger, both of which are...
-
Biogen IDEC Earnings Preview: Analysts Expect Falling Revenue Over Last Quarter
Thursday, July 21, 2011 - 1:43pm | 529Biogen IDEC (NASDAQ: BIIB) unveils its next round of earnings this Tuesday, July 26, 2011. Here is Benzinga's everything-that-matters guide for this Tuesday's second quarter earnings report. Earnings and Revenue: Analysts are predicting a positive EPS reading of $1.37 per share and revenues of $1...
-
Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter
Thursday, July 21, 2011 - 1:12pm | 599Gilead Sciences (NASDAQ: GILD) announces its next round of earnings this Tuesday, July 26, 2011. Here's Benzinga's guide to Gilead Sciences' second quarter earnings report. Earnings and Revenue: Ahead of the company's earnings announcement, analysts are expecting a positive EPS reading of 96...
-
Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum
Thursday, July 21, 2011 - 9:44am | 135The Perrigo Company (Nasdaq: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex gum USP, 2 mg and 4 mg cinnamon flavor. The product will be marketed under store brand labels and is comparable to...
-
Abbott to Feature Acute HIV Diagnostic, Metabolic Function Tests and Lab Informatics at American Association for Clinical Chemistry Annual Meeting
Thursday, July 21, 2011 - 9:06am | 144Abbott (NYSE: ABT) announced its schedule of key workshops and scientific presentations at the American Association for Clinical Chemistry annual meeting, July 24-28 in Atlanta. The company will sponsor four scientific industry workshops covering topics such as HIV, transplant and vitamin D...
-
News Summary for July 20, 2011
Thursday, July 21, 2011 - 7:53am | 701This is your Benzinga news summary and traders' outlook for Thursday, July 21, 2011, covering headlines from overnight and Thursday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading slightly lower as traders wait for several blue-chip companies to report...